Streetbeat News

Products Services

EXEL

Exelixis has settled its patent litigation with Cipla, granting Cipla a license to market generic versions of CABOMETYX starting January 1, 2031, pending FDA approval and other conditions. All Hatch-Waxman litigation regarding CABOMETYX has been terminated.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:17 pm

BIOR

Biora Therapeutics, Inc. (NASDAQ:BIOR) presented clinical data on the NaviCap™ Targeted Oral Delivery Platform at the Digestive Disease Week 2024 conference. The data focused on the device's function in healthy volunteers and patients with ulcerative colitis (UC).

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:15 pm

NVDA

Nvidia's CEO Jensen Huang, despite being one of the richest people in the world, shows no signs of slowing down. He enjoys his role and finds everything else undesirable. Nvidia holds a 70% market share in AI chips.

Portfolio Pulse from Rounak Jain

May 20, 2024 | 12:15 pm

NDRA

ENDRA Life Sciences reviews a constructive FDA meeting and plans to update its clinical study protocol and statistical plan for submission to the FDA before initiating the study.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:14 pm

WU

Western Union has integrated its money transfer services with GraceKennedy's GKOne and Lynk mobile wallet apps, allowing Jamaicans to receive funds digitally. This move enhances Western Union's digital capabilities and provides customers with more options for accessing remittances.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:13 pm

MIRA

Mira Pharmaceuticals is advancing its preclinical studies using Ketamir-2 towards clinical development, indicating progress in their drug development pipeline.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:11 pm

JNJ

Johnson & Johnson announced that its Phase 3 QUASAR Maintenance Study for TREMFYA in treating ulcerative colitis met its primary and all major secondary endpoints, showing significant rates of clinical and endoscopic remission.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:11 pm

AMRC

Ameresco has been awarded a $21 million contract by the City of Henderson to upgrade its street lighting infrastructure. This project involves a streetlight conversion design-build initiative.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:10 pm

NKGN

NKGen Biotech shares are trading higher after the company's SNK01 NK Cell Therapy was cleared to begin a Phase 2 trial in Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:08 pm

ENSC

Ensysce Biosciences has renewed its collaboration with Quotient Sciences to conduct a study on the full commercial dose range of its breakthrough opioid product, PF614-MPAR, which aims to prevent overdose by shutting off opioid release when too many pills are ingested.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:07 pm